These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11249722)

  • 21. Gastric emptying effect by 4-aminopyridine in patients with chronic spinal cord injury.
    Grijalva I; Guízar-Sahagún G; Rodríguez-Pacheco D; Francisco-Argüelles C; Castañeda-Hernández G; Palma-Aguirre JA
    Arch Med Res; 2007 May; 38(4):392-7. PubMed ID: 17416285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dalfampridine in multiple sclerosis.
    Goodman AD; Hyland M
    Drugs Today (Barc); 2010 Sep; 46(9):635-9. PubMed ID: 20967295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic studies of single and multiple oral doses of fampridine-SR (sustained-release 4-aminopyridine) in patients with chronic spinal cord injury.
    Hayes KC; Potter PJ; Hansebout RR; Bugaresti JM; Hsieh JT; Nicosia S; Katz MA; Blight AR; Cohen R
    Clin Neuropharmacol; 2003; 26(4):185-92. PubMed ID: 12897638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carebastine Almirall Prodesfarma.
    Kingham P
    Curr Opin Investig Drugs; 2000 Sep; 1(1):90-6. PubMed ID: 11249602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).
    Preiningerova JL; Baumhackl U; Csepany T; Czaplinski A; Deisenhammer F; Derfuss T; Fabjan TH; Fazekas F; Fuchs S; Havrdova E; Ledinek AH; Illes Z; Jazbec SS; Klimova E; Komoly S; Kurca E; Linnebank M; Lisy L; Mares J; Prochazkova L; Csilla R; Szilasiova J; Stourac P; Talab R; Turcani P; Vachova M; Vecsei L; Vodusek D; Zapletalova O; Berger T
    CNS Neurosci Ther; 2013 May; 19(5):302-6. PubMed ID: 23607697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GW-1000. GW Pharmaceuticals.
    Smith PF
    Curr Opin Investig Drugs; 2004 Jul; 5(7):748-54. PubMed ID: 15298072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease.
    Smith DT; Shi R; Borgens RB; McBride JM; Jackson K; Byrn SR
    Eur J Med Chem; 2005 Sep; 40(9):908-17. PubMed ID: 16055230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleconaril Sanofi Synthélabo/ViroPharma.
    Billich A
    Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AnergiX.RA Corixa.
    Prokaeva T
    Curr Opin Investig Drugs; 2000 Sep; 1(1):70-4. PubMed ID: 11249598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP-10 (AVANT Immunotherapeutics).
    Rioux P
    Curr Opin Investig Drugs; 2001 Mar; 2(3):364-71. PubMed ID: 11575706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral heparin (Emisphere).
    Dunn A
    IDrugs; 2000 Jul; 3(7):817-24. PubMed ID: 16080057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury.
    Hayes KC; Potter PJ; Hsieh JT; Katz MA; Blight AR; Cohen R
    Arch Phys Med Rehabil; 2004 Jan; 85(1):29-34. PubMed ID: 14970964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis.
    Mathiesen HK; Sorensen PS
    Expert Rev Neurother; 2013 Dec; 13(12):1309-17. PubMed ID: 24236901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylprednisolone suleptanate Pharmacia Corp.
    Paggiaro P
    Curr Opin Investig Drugs; 2000 Sep; 1(1):97-103. PubMed ID: 11249603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].
    Husseini L; Leussink VI; Kieseier BC; Hartung HP
    Nervenarzt; 2010 Feb; 81(2):203-11. PubMed ID: 20112006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury.
    McBride JM; Smith DT; Byrn SR; Borgens RB; Shi R
    Neuroscience; 2007 Aug; 148(1):44-52. PubMed ID: 17629412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranolazine (Roche Bioscience).
    Jones R
    IDrugs; 1999 Dec; 2(12):1353-62. PubMed ID: 16113967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ximelagatran (AstraZeneca).
    Hopfner R
    Curr Opin Investig Drugs; 2002 Feb; 3(2):246-51. PubMed ID: 12020054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEE-03-310 CeNeS pharmaceuticals.
    Eder DN
    Curr Opin Investig Drugs; 2002 Feb; 3(2):284-8. PubMed ID: 12020061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deramciclane (Egis).
    Kõks S; Vasar E
    Curr Opin Investig Drugs; 2002 Feb; 3(2):289-94. PubMed ID: 12020062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.